National Institutes of Health scientists studying SARS-CoV-2, the virus that causes COVID-19, have defined in Syrian hamsters how different routes of virus exposure are linked to disease severity. Their study, published in Nature Communications, details the efficiency of airborne transmission between hamsters and examines how the virus replicates and causes disease throughout the respiratory system. Their work also shows that virus transmission via fomites — exposure from contaminated surface contact — is markedly less efficient than airborne transmission but does occur.
Scientists from NIH’s National Institute of Allergy and Infectious Diseases conducted the experiments at Rocky Mountain Laboratories in Hamilton, Montana.
To investigate how different routes of exposure affected disease development, the scientists exposed hamsters to SARS-CoV-2 via both aerosols and fomites. For aerosol exposure, the scientists used equipment that controlled the size of virus-loaded droplets. For fomite exposure, they placed a dish contaminated with SARS-CoV-2 in the animal cages.
The scientists found that aerosol exposure directly deposited SARS-CoV-2 deep into the lungs, whereas fomite exposure resulted in initial virus replication in the nose. Regardless of exposure route, animals had SARS-CoV-2 replicating in the lungs, but lung damage was more severe in aerosol-exposed animals compared to the fomite group.
A second part of the study compared animal-to-animal transmission of the virus through the air and in contaminated cage environments (fomites). Airborne transmission was markedly more efficient compared to fomite transmission, suggesting that airborne droplets are a key SARS-CoV-2 transmission route. An additional experiment, using air flowing from infected to uninfected animals, supported the finding: Reversing the airflow from uninfected to infected animals greatly reduced transmission efficiency.
The findings support public health guidance focused on interventions to reduce indoor airborne transmission of SARS-CoV-2. These efforts include masking, increasing air filtration and social distancing, as well as handwashing and regular surface disinfection, particularly in clinical settings.
Materials provided by NIH/National Institute of Allergy and Infectious Diseases. Note: Content may be edited for style and length.
View original article here Source